Top compounds associated with response to TCF19


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0005
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.12 0.0007
mRNA THZ-2-49 GDSC1000 pan-cancer AAC -0.11 0.0007
mRNA Tipifarnib GDSC1000 pan-cancer AAC -0.12 0.0008
mRNA lapatinib GDSC1000 pan-cancer AAC -0.17 0.0009
mRNA PFI-1 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA bendamustine CTRPv2 pan-cancer AAC 0.13 0.001
Download CSV